Literature DB >> 11428924

Discovery of novel mesangial cell proliferation inhibitors using a three-dimensional database searching method.

Y Kurogi1, K Miyata, T Okamura, K Hashimoto, K Tsutsumi, M Nasu, M Moriyasu.   

Abstract

A three-dimensional pharmacophore model of mesangial cell (MC) proliferation inhibitors was generated from a training set of 4-(diethoxyphosphoryl)methyl-N-(3-phenyl-[1,2,4]thiadiazol-5-yl)benzamide, 2, and its derivatives using the Catalyst/HIPHOP software program. On the basis of the in vitro MC proliferation inhibitory activity, a pharmacophore model was generated as seven features consisting of two hydrophobic regions, two hydrophobic aromatic regions, and three hydrogen bond acceptors. Using this model as a three-dimensional query to search the Maybridge database, structurally novel 41 compounds were identified. The evaluation of MC proliferation inhibitory activity using available samples from the 41 identified compounds exhibited over 50% inhibitory activity at the 100 nM range. Interestingly, the newly identified compounds by the 3D database searching method exhibited the reduced inhibition of normal proximal tubular epithelial cell proliferation compared to a training set of compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428924     DOI: 10.1021/jm010060v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

2.  Molecular modeling study on chemically diverse series of cyclooxygenase-2 selective inhibitors: generation of predictive pharmacophore model using catalyst.

Authors:  Madhu Chopra; Ruby Gupta; Swati Gupta; Daman Saluja
Journal:  J Mol Model       Date:  2008-07-30       Impact factor: 1.810

3.  Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.

Authors:  Yi Liu; Zong Bao Wang; Wei Dong Yin; Qin Kai Li; Man Bo Cai; Jian Yu; Hong Guang Li; Chi Zhang; Xiu Hong Zu
Journal:  Lipids Health Dis       Date:  2011-07-16       Impact factor: 3.876

4.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods and applications.

Authors:  Mingzhu Zhao; Dongqing Wei
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

Review 6.  In silico pharmacology for drug discovery: applications to targets and beyond.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

7.  In silico design and analysis of a new hyperglycosylated analog of erythropoietin to improve drug efficacy.

Authors:  Anvarsadat Kianmehr; Hamid Shahbaz Mohammadi; Mohammad Ali Shokrgozar; Eskandar Omidinia
Journal:  Adv Biomed Res       Date:  2015-07-27

8.  Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.

Authors:  Sanghamitra Bandyopadhyay; Catherine Cahill; Amelie Balleidier; Conan Huang; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.